HBM Partners

What is HBM Partners?

HBM Partners is a Swiss asset management firm that has specialized in the healthcare sector since its inception in 2001. With USD 2.1 billion in assets under management, HBM Partners primarily engages in venture capital, growth capital, and buy-out financings for private companies, as well as investments in public equity markets.

They are focused on catering to the biopharma, medtech, diagnostics, and healthcare sectors across Europe and North America, with additional investments in India, China, and other emerging markets. HBM Partners advises the SIX-listed HBM Healthcare Investments Ltd along with several specialized private and public equity investment funds.

With FINMA regulation secured, HBM Partners has made a strong impact in the healthcare investment landscape, evidenced by their formidable track record of over 100 investments which have led to more than 60 trade sales and initial public offerings (IPOs), driving significant value creation.

Their investments typically range from USD 5 million to USD 50 million.

The team at HBM Partners consists of seasoned professionals who are committed to sourcing, analyzing, and engaging in private and public healthcare investments. They are actively involved in the growth of their portfolio companies, guiding them through all stages of development, and strive to add value by leveraging their experience and worldwide industry network.

CEO Dr. Andreas Wicki emphasizes HBM Partners' commitment to supporting exceptional entrepreneurs and partnering with them to develop innovative ventures and build outstanding companies.